Abbreviations used in this paper: A/B, apicobasal; Co-IP, coimmunoprecipitation; Crb, Crumbs; Dhc64C, *Drosophila melanogaster* dynein heavy chain 64C; EMS, ethyl methanesulfonate; FC, follicle cell; MT, microtubule; Sdt, Stardust; UTR, untranslated region; wt, wild type.

Introduction
============

Metazoan epithelial cells are polarized along the apicobasal (A/B) axis and this polarization is important for the formation and function of the epithelial structures they comprise ([@bib25]; [@bib12]; [@bib14]; [@bib13]; [@bib17]). Along with this polarization, their plasma membranes are compartmentalized into several distinct domains with different protein complexes differentially localized along the A/B axis, including the Crumbs (Crb) complex (Crb, Stardust \[Sdt\], and Patj/Dlt), the PAR complex (PAR-3, PAR-6, and aPKC), and the Scribble complex (Discs large, Lethal giant larvae, and Scribble). Genetic studies in *Drosophila melanogaster* have revealed that these protein complexes function in a sequential yet interdependent manner to regulate the establishment, elaboration, and maintenance of cellular polarity ([@bib25]; [@bib4]; [@bib22]). The transmembrane protein Crb localizes on the apical domain and acts as an apical domain determinant by organizing a protein network that regulates A/B polarity ([@bib24]; [@bib28]). However, it is unclear how Crb is targeted onto the apical domain.

There are at least two mechanisms for the asymmetrical deployment of proteins ([@bib2]). The first relies on the subcellular trafficking of proteins via the trans-Golgi network ([@bib16]). Polarized deployment of the majority of transmembrane and secreted proteins is believed to be mediated by this mechanism ([@bib15]). The second mechanism involves polarized localization of transcripts before translation ([@bib20]). These transcripts encode a variety of cytosolic proteins, ranging from transcription factors to cytoskeletal proteins. However, there are relatively few reported examples of localized transcripts encoding transmembrane proteins and the functional relevance of these localized transcripts remains to be investigated ([@bib21]; [@bib5]; [@bib10]).

Results and discussion
======================

To identify genes that regulate epithelial polarity, we performed a mosaic screen in *D. melanogaster* follicle cells (FCs) and identified mutants in *D. melanogaster* dynein heavy chain 64C (Dhc64C) and the dynactin component *Glued/p150*, which disrupt FC A/B polarity (see Materials and methods and Fig. S1, available at <http://www.jcb.org/cgi/content/full/jcb.200707007/DC1>, for screen and mapping details). In the wild type (wt), the FCs are polarized along the A/B axis and form a single layer enclosing the developing germ cells (100%, *n* \> 1,000; [Fig. 1, A and D](#fig1){ref-type="fig"}). However, *Dhc64C^902^* and *Glued^1L^* mutant FCs often became multiple layered when located at the posterior end of the follicle after stage six (98%, *n* = 125), which indicates a loss of A/B polarity ([Fig. 1, B, C, E, and F](#fig1){ref-type="fig"}). Examination of known polarized membrane markers showed that *Dhc64C^902^* and *Glued^1L^* mutants primarily affect apical localization of the Crb complex without markedly affecting localization of the other polarity complexes regardless of the position and developmental stage of the mutant clones induced. Crb localizes to the apical region in wt FCs (100%, *n* \> 1,000) but is absent from the apical region in both *Dhc64C^902^* and *Glued^1L^* mutant FCs (100%, *n* = 245; [Fig. 2, A--C](#fig2){ref-type="fig"}), whereas Sdt and Patj/Dlt showed cytoplasmic localization (100%, *n* = 156; see [Fig. 4, A--F](#fig4){ref-type="fig"}). The adherens junction (Armadillo; 100%, *n* = 175), as well as the PAR complex (aPKC; 100%, *n* = 212) largely retained their normal localization, although their levels were somewhat reduced ([Fig. 2, D--I](#fig2){ref-type="fig"}); the lateral Scribble complex was slightly expanded into the apical domain (100%, *n* = 260; [Fig. 2, J--L](#fig2){ref-type="fig"}). Identical phenotypes were also observed in previously identified alleles (*Dhc64C^4-19^* and *Glued^1^*) or when p25 (another subunit of dynactin) function was compromised using double-stranded RNA--mediated knockdown (termed *p25^RNAi^*; Fig. S2 and not depicted). Although recent data showed that dynein activity is required for Bazooka (Baz, the fly homologue of Par3) localization in embryonic epithelia ([@bib8]), our data favor the model that dynein functions primarily through the Crb complex to establish FC polarity. This may reflect the different requirement of these two systems. A wt *Dhc64C* transgene fully rescued the polarity defects in *Dhc64C* ^902^ mutant FCs (100%, *n* \> 500; Fig. S1). Dynein and dynactin form a complex that mediates microtubule (MT)-based transport and both *Dhc64C^902^* and *Glued^1L^* mutants showed virtually identical polarity defects. For simplicity, we show data mainly for *Dhc64C^902^*.

![**Dynein function is required for FC A/B polarity.** GFPnls are shown as green, DNA is shown as blue, and mutant clones are marked by the absence of GFP and apical up unless otherwise stated. (A) wt FCs display regular cuboidal morphology by rhodamine phalloidin staining (red). *Dhc64C^902^* (B) and *Gl^1L^* (C) mutant FCs show altered morphology. wt FCs are monolayered (D), whereas *Dhc64C^902^* (E) and *Gl^1L^* (F) mutant FCs are multiple layered at the posterior end. Bars, 5 μm.](jcb1800031f01){#fig1}

![**Dynein is required for the apical localization of the Crb complex.** Rhodamine phalloidin is shown in red and GFPnls is shown in green. Crb (blue) localizes to the apical domain of wt FCs (A) but is lost from the apical domain in the dynein mutant and colchicine-treated FCs (B, C, and M). Arm (blue) localizes to the adherens junctions in wt FCs (D) and this localization is largely normal in dynein mutant and colchicine-treated FCs (E, F, and N). aPKC (blue) localizes to the apical region of wt FCs (G) and is largely unaffected in dynein mutant and colchicine-treated FCs (H, I, and O). Scrib (blue) localizes along the lateral domain of wt FCs (J) and is only slightly apically expanded in the dynein mutant cells (K, L, and P). Bars, 5 μm.](jcb1800031f02){#fig2}

The dynein complex transports cargos toward MT minus ends. To examine the effects of disrupting the MT cytoskeleton, we used colchicine to depolymerize MTs. Similar polarity defects were observed in these FCs with specific loss of Crb from their apical domains without markedly affecting other cell polarity complexes (100%, *n* \> 200 for each marker; [Fig. 2, M--P](#fig2){ref-type="fig"}). Furthermore, the MT cytoskeleton is largely unaffected in dynein mutant FCs (unpublished data), which is consistent with the notion that the observed polarity defects seen in *dynein* mutant and MT-depolymerized FCs are caused by defective dynein-mediated transport.

We next investigated how dynein mediates the apical localization of Crb. Restricted mRNA localization coupled with local translation is widely used to generate cellular asymmetry. It has been reported that *crb* mRNA localizes apically in embryonic epithelia ([@bib24]). This prompted us to investigate whether dynein functions via the localization of *crb* mRNA to localize Crb protein.

In the wt, *crb* mRNA is highly enriched on the apical domain. However, in the dynein mutant, *crb* mRNA is no longer apically enriched (100%, *n* = 241; [Fig. 3, A and B](#fig3){ref-type="fig"}; and Fig. S3, available at <http://www.jcb.org/cgi/content/full/jcb.200707007/DC1>). Consistent with the notion that dynein-mediated transport requires an intact MT cytoskeleton, *crb* mRNA is mislocalized in colchicine-treated FCs (100%, *n* = 127; Fig. S3). Together, these data show that *crb* mRNA localizes to the apical domain via dynein-mediated transport.

![**Apical *crb* transcript localization is required for Crb activity.** Crb protein is shown in red, and *crb* mRNA (green) localizes apically in wt FCs (A) but delocalizes in the dynein mutant (B). Injected *crb^intra-myc^* transcripts (red) localize apically in wt (C) and anti-Myc 9E10 antibody--treated (F) but not in P1H4 (anti-Dhc64C) antibody--treated or colchicine-treated blastoderm embryos (D and E). *crb^intra-myc-wo^* transcripts (red) fail to localize apically in wt blastoderm embryos (G). *lacZ-crb 3′* UTR (H, red) but not *lacZ-SV40 3′* UTR transcripts (I, red) localize apically in blastoderm embryos. *crb^intra-myc^* transcripts (J) but not *crb^intra-myc-wo^* (K) transcripts (green) localize apically in FCs. In J and K, both endogenous and exogenous transcripts are detected. Crb^intra-myc^ protein (green) shows apical localization in wt FCs (L). The majority of Crb^intra-myc-wo^ protein (green) is apically localized in wt FCs (M). In 5% of cells, Crb^intra-myc-wo^ (green) shows cytoplasmic localization (N). Crb^intra-myc^ (O, red) apically localizes in the *crb* mutant. Crb^intra-myc-wo^ (P, red) is largely cytoplasmic in the *crb* mutant. In *crb* mutant FCs, apical localization of Sdt (Q and R, red) is restored by expression of *crb^intra-myc^* but not the *crb^intra-myc-wo^* transgene (also note the multilayering of mutant cells in R). In Q and R, GFP is in green and mutant cells do not express GFP. Bars, 5 μm.](jcb1800031f03){#fig3}

Because of difficulties in studying how dynein transports *crb* mRNA in FCs, we examined *crb* mRNA localization in blastoderm embryos, as it has been found that dynein-mediated transport is conserved between embryogenesis and oogenesis ([@bib11]; [@bib6]). We took advantage of a functional *crb* minigene, *crb^intra-myc^* (this minigene contains the *crb* 3′ untranslated region \[UTR\]; see Fig. S2 for a schematic presentation of the transcripts used in this study; [@bib28]). Fluorescently labeled *crb^intra-myc^* transcripts rapidly localized to the apical domain after injection into the basal cytoplasm of embryos (100%, *n* = 13; [Fig. 3 C](#fig3){ref-type="fig"}). However, preinjection with the anti-Dhc64C antibody P1H4 (100%, *n* = 12) or colchicine (100%, *n* = 9) but not anti-Myc antibody (100%, *n* = 8) completely blocked apical localization of *crb^intra-myc^* transcripts ([Fig. 3, D--F](#fig3){ref-type="fig"}). These data demonstrate that dynein activity is required for the apical localization of in vitro labeled *crb* transcripts in embryos.

To test whether the *crb* 3′ UTR mediates its localization, we injected *crb^intra-myc-wo^*, in which the *crb* 3′ UTR was replaced by the 3′ UTR of the SV40 large T antigen, into blastoderm embryos ([@bib18]). These transcripts did not localize apically, which suggests that the *crb* 3′ UTR is required for its apical localization (100%, *n* = 9; [Fig. 3 G](#fig3){ref-type="fig"}). In a complementary experiment, we fused the *crb* 3′ UTR to an exogenous β-galactosidase gene and found that this chimeric transcript localized apically (100%, *n* = 10; [Fig. 3 H](#fig3){ref-type="fig"}) when injected into the embryo, whereas control β-galactosidase transcripts (lacZ-*SV40* 3′ UTR) did not (100%, *n* = 8; [Fig. 3 I](#fig3){ref-type="fig"}). We conclude that the *crb* 3′ UTR is necessary and sufficient for its apical localization in embryos. We next investigated whether the *crb* 3′ UTR also mediates its apical localization in FCs. We again used *crb^intra-myc^* and *crb^intra-myc-wo^* minigenes and the subcellular localization of these transcripts was determined by RNA in situ. When ectopically expressed in wt FCs, *crb^intra-myc^* transcripts were predominantly found on the apical domain, whereas *crb^intra-myc-wo^* transcripts were unlocalized ([Fig. 3, J and K](#fig3){ref-type="fig"}; and Fig. S3, compare with endogenous *crb* transcripts in [Fig. 3 A](#fig3){ref-type="fig"}). Together, these results demonstrate that the *crb* 3′ UTR mediates apical localization of *crb* transcripts in FCs.

Next, we investigated whether apical localization of *crb* transcripts is a prerequisite for Crb protein localization. Both transgenes are expressed at an equivalent level when driven by the same driver in both FCs and embryos, which suggests that the different 3′ UTRs do not affect protein expression levels (Fig. S2 F). In wt FCs, both *crb^intra-myc^* transcripts and Crb^intra-myc^ protein localized to the apical domain (100%, *n* \> 200; [Fig. 3, J and L](#fig3){ref-type="fig"}). Interestingly, in wt FCs expressing *crb^intra-myc-wo^*, *crb^intra-myc-wo^* transcripts did not apically localize ([Fig. 3 K](#fig3){ref-type="fig"}), yet Crb^intra-myc-wo^ protein remained localized to the apical domain in the great majority of FCs (95%, *n* = 73) in several independent transgenic lines ([Fig. 3 M](#fig3){ref-type="fig"} and not depicted). Only in ∼5% (*n* = 73) of the FCs examined did Crb^intra-myc-wo^ protein show cytoplasmic localization ([Fig. 3 N](#fig3){ref-type="fig"}). These results suggest that apical localization of Crb protein can be independent of apical transcript localization and that dynein also transports Crb protein to the apical domain. It was found that endogenous *oskar* mRNA can direct the proper localization of exogenous transcripts derived from a transgene bearing the *oskar* 3′ UTR during *D. melanogaster* oogenesis ([@bib7]). Thus, it is possible that endogenous *crb* transcripts/protein may have an impact on the behavior of these transgene products. Therefore, we examined the behavior of the transgene products in a *crb* mutant background where endogenous Crb protein is absent. Interestingly, although Crb^intra-myc^ efficiently localized to the apical domain in the *crb* mutant (100%, *n* = 66), Crb^intra-myc-wo^ showed largely cytoplasmic localization in 64.3% (*n* = 45) of the *crb* mutants ([Fig. 3, O and P](#fig3){ref-type="fig"}). Thus, endogenous wt *crb* product is required, directly or indirectly, for the apical localization of exogenous Crb^intra-myc-wo^, although the reasons for this remain unclear. These data suggest that, in *crb* mutant FCs, Crb^intra-myc-wo^ protein, derived from transcripts that do not apically localize, is not effectively localized to the apical domain.

Thus far, we have shown that apical localization of *crb* mRNA contributes to the apical localization of Crb protein. Does this have any functional relevance? Consistent with previous reports that Crb^intra-myc^ can rescue *crb* mutant defects in embryonic epithelial cells ([@bib28]), apically localized Crb^intra-myc^ recruits Sdt to the apical region and fully rescues the polarity defects in *crb* mutant FCs (100%, *n* = 55; [Fig. 3 Q](#fig3){ref-type="fig"}). However, in 60% (*n* = 20) of *crb* mutant FCs expressing *crb^intra-myc-wo^*, Sdt remains in the cytoplasm and polarity defects are not rescued, which is consistent with the Crb^intra-myc-wo^ localization in *crb* mutant FCs ([Fig. 3 R](#fig3){ref-type="fig"}). These data strongly indicate that apical localization of the *crb* transcripts is required for effective *crb* function in epithelial polarity. Furthermore, these results suggest that a localized translational machinery near the apical domain may be involved in the generation of full Crb activity on the apical domain.

It has been found that, in embryonic epithelial cells, Crb binds Sdt and the two are mutually dependent for their localization and function ([@bib23]; [@bib1]; [@bib9]). Crb protein levels are markedly reduced in the *sdt* mutant and vice versa. Our data show that in dynein mutant FCs, Crb is undetectable by immunofluoresence, whereas Sdt is mainly cytoplasmic ([Fig. 4, A--C](#fig4){ref-type="fig"}). There are several possibilities for the inability to detect Crb in the dynein mutant. First, the apical localization and stability of Crb requires dynein activity. In the absence of dynein function, unlocalized Crb is not stable and is degraded. Second, the apical localization but not stability of Crb requires dynein activity. In the dynein mutant, Crb may be uniformly distributed in the cytoplasm and hence fall below the threshold of detection by immunoflourescence. To address these possibilities, we took advantage of MT-depolymerized FCs that mimic the effects of dynein mutants ([Fig. 2, M--P](#fig2){ref-type="fig"}). Interestingly, although no protein can be detected in these FCs by immunostaining, normal levels of Crb protein are detectable by Western blotting ([Fig. 4 L](#fig4){ref-type="fig"}), which is consistent with the notion that the apical localization but not stability of Crb requires dynein activity. Furthermore, in the *crb* mutant, Sdt also displays cytosolic localization ([Fig. 4, G--I](#fig4){ref-type="fig"}), suggesting that apical localization but not stability of Sdt protein requires Crb activity.

![**Crb and Sdt interact on the apical cortex.** Sdt (red) localizes on the apical cortex in wt FCs (A). Sdt localization in newly induced (B) and aged dynein mutant clones (C). Patj/Dlt (red) localizes on the apical domain in wt FCs (D) and gradually localizes into the cytoplasm in the dynein mutant (E, a mutant clone shortly after induction; F, an aged mutant clone). Sdt gradually delocalizes in *crb* mutant cells (G, early clone; H and I, aged clone). Sdt (red) largely colocalizes with Crb^intra-myc^ (green) on the apical domain in wt FCs (J). Both Sdt and Crb^intra-myc^ become cytoplasmic and do not colocalize in colchicine-treated FCs, which mimic dynein mutant FCs (K). Equal protein loadings of total lysates from wt (left lane) and colchicine-treated ovary (right lane) were probed with an anti-Crb antibody (L); loading control was probed with an anti--α-tubulin antibody (L\'). Crb^intra-myc^ and Sdt only form a complex when both localize on the apical cortex (M). Western blot is probed with Sdt. (lane 1) wt (*crb^intra-myc^* expressed in wt background) input (10%). (lane 2) Anti-Myc immunoprecipitation from wt sample. (lane 3) Anti-Flag immunoprecipitation (negative control) from wt sample. (lane 4) Anti-Myc immunoprecipitation from a colchicine-treated sample. (lane 5) Anti-Flag immunoprecipitation (control) from a colchicine-treated sample. Bars, 5 μm.](jcb1800031f04){#fig4}

We next examined whether Crb and Sdt form a complex when in the cytosol. When expressed in wt FCs, Crb^intra-myc^ largely colocalizes with Sdt on the apical domain ([Fig. 4 J](#fig4){ref-type="fig"}). In addition, an anti-Myc antibody can bring down Sdt in coimmunoprecipitation (Co-IP) experiments ([Fig. 4 M](#fig4){ref-type="fig"}, lane 2). These suggest that in the wt, Crb^intra-myc^ forms a complex with Sdt. In the *crb* mutant, whenever Crb^intra-myc-wo^ apically localized, it colocalized with Sdt. However, when Crb^intra-myc-wo^ was found in the cytosol, it did not colocalize well with Sdt (unpublished data), which suggests that these two molecules may not form a complex when not localized. To test this possibility, we again took advantage of colchicine-treated FCs. When ectopically expressed in colchicine-treated FCs, Crb^intra-myc^ does not bring down Sdt in Co-IP experiments, which suggests that these proteins do not form a complex when both are cytoplasmic ([Fig. 4 M](#fig4){ref-type="fig"}). Similarly, an anti-Crb antibody could bring down Sdt in wt FCs but not *p25^RNAi^* FCs, confirming that colchicine-treated FCs actually reflect loss of dynein activity and not other MT-based activity (Fig. S2). Collectively, these data suggest that Crb and Sdt form a complex on the apical cortex and that this complex is stabilized, directly or indirectly, by dynein activity.

When expressed in wt FCs (in the presence of wt *crb*), Crb^intra-myc^ localizes apically and forms a complex with Sdt. However, in dynein mutant FCs (in the presence of wt *crb*), Crb^intra-myc^ is localized to the cytoplasm and does not form a complex with Sdt ([Figs. 4](#fig4){ref-type="fig"} and S2). Our data suggest that in the wt, an endogenous *crb* product is required, directly or indirectly, for the apical localization of exogenous Crb^intra-myc^ protein. It is possible that apically localized endogenous Crb could be involved in this process via its requirement for A/B polarity, which in turn directs exogenous Crb^intra-myc^ apical localization and subsequently allows the formation of the Crb--Sdt complex. In the dynein mutant, although endogenous Crb is still present (as confirmed by Western blotting), it is not localized apically. As a result, A/B polarity is not properly established. Consequently, exogenous Crb does not form a complex with cytoplasmic Sdt when in the cytosol.

Our data suggest that dynein transports both Crb protein and mRNA to the apical domain, where Crb protein interacts with Sdt to form an apical complex. The *crb* 3′ UTR is necessary and sufficient for the apical localization of *crb* mRNA. The apical localization of *crb* mRNA appears to be crucial for *crb* function. *crb^intra-myc^* produces transcripts and protein that apically localize and can fully rescue the polarity defects associated with *crb* mutant FCs. In contrast, *crb^intra-myc-wo^* produces transcripts and proteins that do not fully localize apically and show reduced ability to rescue the polarity defects of *crb* mutant FCs. Based on these observations, we propose that localized transcripts coupled with a local translation mechanism contribute to the apical localization of Crb and its ability to mediate epithelial polarity.

In general, transmembrane proteins are cotranslationally inserted into the ER and trafficked via the exocytic pathway to the plasma membrane. How might the transmembrane Crb protein be translated and inserted into the plasma membrane near the apical domain? One precedent comes from the study of the budding yeast membrane protein Ist2p ([@bib10]). *Ist2* mRNA is asymmetrically localized to the cortex of daughter cells and a localized transcript is required for the accumulation of Ist2p at the plasma membrane of daughter but not mother cells. This asymmetrical delivery of Ist2p does not require the normal secretory pathway but rather suggests that the localized *Ist2* transcripts are translated by specialized subcortical domains of the ER (small daughter cells contain only cortical and not perinuclear ER) and trafficked via a novel pathway linking these specialized ER domains with the plasma membrane. More generally, during vertebrate axon growth, transcripts encoding an Eph2A receptor are locally translated and their protein products can be exported to the cell surface ([@bib5]). Our observations suggest that transcripts of the transmembrane protein Crb may be locally translated near the apical domain and that this mechanism contributes to epithelial A/B polarity. As the *crb* 3′ UTR is highly conserved through evolution (unpublished data), together with the conserved function of MT-based dynein activity, our results suggest that this directional transport of mRNA plus local translation may be a widely used mechanism to generate epithelial polarity.

Materials and methods
=====================

Fly genetics
------------

Stocks were raised on standard cornmeal-agar medium at 25°C. Information about strains used in this study is described in the text or in FlyBase. The following strains are used: y^1^w^1118^, *Dhc64C^902^*, *Glued^1L^*, *Dhc64C ^4-19^*, *Glued^1^*, *Df(3l)10H*, p(Dhc64C), *sdt^EH^* (a gift of E. Knust, Max Planck Institute of Molecular Biology and Genetics, Dresden, Germany), *crb^11A22^*, *UAS-crb^intra-myc^*, *p25^RNAi^*, and AyGal4-uas-lacZ.

Rescue experiments were performed in p{Dhc64C }/+;*Dhc64C^902^*/10H flies. Mutant clones were generated by the FLP-FRT technique ([@bib29]). Clones were induced by heat shock during third instar larvae for 2 h on two consecutive days. Adult flies were dissected 3--5 d after eclosion.

Ethyl methanesulfonate (EMS) mutagenesis screen
-----------------------------------------------

An FLP-FRT--mediated mosaic screen was performed as follows. hs-flp; FRT79D-ubi-GFP virgins were crossed with EMS-mutagenized males carrying an FRT79D chromosome ([@bib19]). The progenies were grown at room temperature until third instar larvae, which were then subjected to heat shock to induce mitotic clones ([@bib29]). Adult progenies were aged for 4--6 d before dissection and stained with rhodamine phalloidin and DNA dye (To-Pro 3; Invitrogen) to visualize cell morphology. In this screen, two EMS lines (*902* and *1L*) were recovered that showed cell morphological change and formed multiply layers when mutant clones were generated in the posterior end of follicle, which implies a loss of cell polarity. Both 902 and 1L homozygous progenies died at first instar larva. Genetic mapping for these two EMS mutations were then performed by using a 3L deficiency kit (Bloomington Drosophila Stock Center). Three deficiency lines including BL3686 (063F06-07; 064C13-15), BL3640 (072A03-04; 072D01-5), and 2993 (072C01-D01; 073A03-04) failed to complement *902. 1L* failed to complement BL6876 (065D04-05; 065E04-06), BL4366 (070A01-02; 070C03-04 + 089; 089), and 3124 (070C01-02; 070D04-05, 066E). Next, a group of overlapping smaller deficiency lines removing the aforementioned chromosome regions was used to complement these two EMS lines to narrow down the genomic region. For *902*, Df BL8061 (64B11-64D1) failed to complement *902*. For *1L*, BL5413 (70C2-6-70E1) failed to complement *1L*. Then, lethal P-element insertion lines in these regions were used for candidate approach mapping. BL5274, a *Dhc64C^4-19^* allele, failed to complement *902*.l(3)S027714, which is *bin^l1^*, and BL5750, the *Glued^1^* allele, failed to complement *1L*. These lethal mutations were recombined onto an FRT79D chromosome and clones were generated to examine the phenotype in follicular cells. Only *Dhc^4-19^* and *Glued^1^* showed identical phenotypes observed in *902* and *1L*. Furthermore, Df(3l)10H, a small deficiency line that deletes the Dhc64C genomic region, failed to complement the 902 allele. The introduction of a copy of transgene *Dhc64C* into 902 not only reverted the lethality of 902 when in transzygous to Df(3l)10H but also fully reverted the FC mutant phenotypes (Fig. S1). Thus, we concluded that 902 is a new *Dhc64C* allele and that 1L is a *Glued* allele; we referred to them as *Dhc64C^902^* and *Glued^1L^*, respectively.

To identify the molecular lesion of these mutations, we sequenced the mutant chromosome loci. Homozygous mutant embryos were collected and genomic DNA was extracted according to standard protocol. 2-kb walking of the genomic region with 1-kb overlapping was performed for the mutants and amplified using amplification primers with Hi-Fi taq polymerase (Invitrogen), and gel was recovered using standard kits (GE Healthcare). The fragments were sequenced using a set of sequencing primers. Sequencing of the *Dhc64C^902^* mutant identified a premature stop codon at Trp^1173^ causing a truncated product before the DHC_N2 domain and deleting all four ATPase domains. Furthermore, no signaling could be detected using an anti-Dhc64C antibody that recognizes the N-terminal region of Dhc64C polypeptide in immunofluorescent staining, which suggests that this is a protein null allele. There is also a premature stop codon identified in *Glued^1L^* mutant (Gln^412^ stop), which lies in the second coiled-coil domain implicated for protein--protein interactions (Fig. S1).

MT drug treatment
-----------------

To depolymerize the MT cytoskeleton, flies were starved at 25°C for 2.5 h and fed with 200 μg/ml colchicines for 24 h before dissection.

Generation of *crb^intra-myc-wo^* transgene stocks
--------------------------------------------------

*crb^intra-myc-wo^* was amplified from a *crb^intra-myc^* transgene fly and cloned into a pUAST vector. This construct was microinjected into FRT82B-*crb^11A22^*/Tm6tb embryos after standard transgene protocol to generate *crb^intra-myc-wo^* transgene stock. Three independent lines were selected for further analysis. Hs-flp; AyGal4-uas-lacZ was used to drive the expression of transgenes in FCs.

In situ hybridization
---------------------

*crb* template was amplified using Crb-5′ (ATTACGGCCAAGGAGGACG) and Crb-3′ (CTAAATTAGTCGCTCTTCCGGC) primers. Probes were digoxigenin labeled according to the manufacturer\'s instructions (Roche). In situ hybridization was performed as described previously using an HRP-conjugated anti-digoxigenin antibody (Roche) and detected with a fluorescein tyramide signal amplification system (PerkinElmer; [@bib27]; [@bib26]).

Capped fluorescent RNA synthesis and injection
----------------------------------------------

*crb^intra-myc^* and *crb^intra-myc-wo^* were amplified from transgenic flies ([@bib28]) using crb-5 (GGGAATTGGGAATTCCCCCCCCCA), crb^intra-myc^-3 (GCTCTAGAGCAAAATATGTTTTTTATTTG), and crb^intra-myc-wo^-3 (AGATCTCTAAATTAGTCGCTCTTCC). The *crb* 3′ UTR was amplified using CGGAATTCTAGTTTTGAGTTTTGAGCATGAACGACG and crb^intra-myc^-3 and cloned into pCS2+. Alexa 543 UTP (Invitrogen) was used to synthesize fluorescent RNA according to the manufacturer\'s directions. Fluorescent RNAs typically contained 1 fluorochrome per 250 nucleotides for Alexa 543--labeled transcripts.

Embyros were injected with 200 ng/μl of labeled RNA. To depolymerize the MT cytoskeleton, 100 μg/ml colchicine (Sigma-Aldrich) was injected 10 min before RNA injection. mAb P1H4 or anti-Myc antibodies were injected 10 min before RNA injection. Injected embryos were imaged in vivo.

Immunocytochemistry
-------------------

Ovaries were fixed according to standard protocols. Anti-Crb (Cq4, 1:50), anti-Arm (N2 7A1, 1:50; Developmental Studies Hybridoma Bank), rabbit anti-aPKC (1:1,000), mouse anti-Flag (1:2,000; Santa Cruz Biotechnology, Inc.), rabbit anti-Patj/Dlt (1:1,000; [@bib3]), rabbit anti-Baz (1:1,000; a gift of F. Matsuzaki, Institute of Physical and Chemical Research Center for Developmental Biology, Kobe, Japan), guinea pig anti-Scrib (1:1,000; a gift of D. Bilder, University of California, Berkeley, Berkeley, CA), rabbit anti-Sdt (1:1,000; [@bib1]), rabbit and mouse anti--c-myc (9E10, 1:500), mouse anti--α-tubulin (1:1,000; Sigma-Aldrich), mouse anti-Dhc64C (P1H4), and rabbit and mouse anti--β-galactosidase (Invitrogen). Fluorescently conjugated goat anti--mouse and rabbit secondary antibodies and rhodamine phalloidin were used (Invitrogen).

Microscopy
----------

Samples were mounted in Vectashield mounting medium (Vector Laboratories). Images were collected using a microscope (Axioplan 2) with an upright confocal system (LSM510 META; both from Carl Zeiss, Inc.) at room temperature. The objective lens used was a Plan NEOFLUAR 40× 1.3 oil and the imaging software used was Zeiss LSM510 (both from Carl Zeiss, Inc.). The confocal images were extracted with LSM510 browser software (Carl Zeiss, Inc.) and then processed in Photoshop 7.0.1 (Adobe). Scale bars are indicted in each individual image.

Immunoprecipitation
-------------------

Ovaries with corresponding genotype were dissected in S2 culture medium (Invitrogen) and collected in PBS buffer. Protein extract and Co-IP experiments were performed according to standard protocols and probed with corresponding antibody ([Fig. 4, L and M](#fig4){ref-type="fig"}) and detected with an ECL kit (Thermo Fisher Scientific).

Online supplemental material
----------------------------

Fig. S1 shows molecular lesions of *Dhc64C^902^* and *Glued^1L^* and the rescue of apical Crb localization in the *Dhc64C^902^* mutant by a *Dhc64C* transgene. Fig. S2 shows phenotypic analyses of *p25^RNAi^* FCs, schematic presentation of the transcripts used in this study, and that Crb forms a complex with Sdt on the apical domain. Fig. S3 shows that apical localization of *crb* transcripts depends on dynein function in FCs. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200707007/DC1>.
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**Note added in proof.** A complementary study examining the contributions of Dynein and Sdt mRNA localization to A/B polarity regulation has been performed (Horne-Badovinac, S., and D. Bilder. 2007. *PLoS Genet*. doi:10.1371/journal.pgen.0040008).

[^1]: Correspondence to Y. Cai: <caiyu@tll.org.sg>
